Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Jun 1, 2026
Reporting period
Not applicable
Filed with the SEC
Jun 3, 2026
DirectorGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0000816956-26-000073
Filed / recorded
Jun 3, 2026, 8:18 PM UTC
Added to OQRO
Oct 6, 2026, 10:14 PM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
CONMED Corp
Issuer CIK
816956
Ticker
CNMD
Reporting person
Laverne H Council
Relationship
Director
Security
RSUs (Restricted Stock Units)
Table
Derivative (Table II)
Transaction date
Jun 1, 2026
Transaction code
A
Shares / units
5,772
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
5,772
Ownership form
Direct
Amendment
No
Footnotes from the filing
Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period.